BG103106A - Таблетки тровафлоксацин мезилат - Google Patents

Таблетки тровафлоксацин мезилат

Info

Publication number
BG103106A
BG103106A BG103106A BG10310699A BG103106A BG 103106 A BG103106 A BG 103106A BG 103106 A BG103106 A BG 103106A BG 10310699 A BG10310699 A BG 10310699A BG 103106 A BG103106 A BG 103106A
Authority
BG
Bulgaria
Prior art keywords
tablets
trovafloxacin mesilate
mesilate
trovafloxacin
compositions
Prior art date
Application number
BG103106A
Other languages
English (en)
Inventor
Alton JOHNSON
Christopher SINKO
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of BG103106A publication Critical patent/BG103106A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретението се отнася до състави, по-специално под формата на таблети, съдържащи полиморф II формата на тровафлоксацин мезилат, смазващо вещество имикрокристална целулоза (МС) като разтворител. Съставите, включващи МС като разтворител, имат добрастабилност при съхраняване на склад и при разтваряне. </P>
BG103106A 1998-01-21 1999-01-21 Таблетки тровафлоксацин мезилат BG103106A (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7201398P 1998-01-21 1998-01-21

Publications (1)

Publication Number Publication Date
BG103106A true BG103106A (bg) 1999-08-31

Family

ID=22105016

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103106A BG103106A (bg) 1998-01-21 1999-01-21 Таблетки тровафлоксацин мезилат

Country Status (34)

Country Link
US (1) US6187341B1 (bg)
EP (1) EP0930068A3 (bg)
JP (1) JPH11269072A (bg)
KR (1) KR100314977B1 (bg)
CN (1) CN1227743A (bg)
AP (1) AP1094A (bg)
AR (1) AR012780A1 (bg)
AU (1) AU758381B2 (bg)
BG (1) BG103106A (bg)
BR (1) BR9900116A (bg)
CA (1) CA2259698C (bg)
CO (1) CO4810225A1 (bg)
DZ (1) DZ2712A1 (bg)
EA (1) EA003247B1 (bg)
GT (1) GT199900004A (bg)
HR (1) HRP990023A2 (bg)
HU (1) HUP9900154A3 (bg)
ID (1) ID23735A (bg)
IL (1) IL128051A0 (bg)
IS (1) IS4947A (bg)
MA (1) MA24747A1 (bg)
NO (1) NO990243L (bg)
NZ (1) NZ333838A (bg)
OA (1) OA10958A (bg)
PA (1) PA8466701A1 (bg)
PE (1) PE20000169A1 (bg)
PL (1) PL330981A1 (bg)
SG (1) SG70666A1 (bg)
SK (1) SK4299A3 (bg)
TN (1) TNSN99007A1 (bg)
TR (1) TR199900089A2 (bg)
TW (1) TW518224B (bg)
YU (1) YU2399A (bg)
ZA (1) ZA99393B (bg)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142642A0 (en) * 1998-11-10 2002-03-10 Bayer Ag Pharmaceutical moxifloxacin preparation
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
IL148820A0 (en) * 1999-10-08 2002-09-12 Smithkline Beecham Corp Fab i inhibitors
FR2808441B1 (fr) * 2000-05-04 2004-06-18 Oreal Utilisation de fibres dans une composition de soin ou de maquillage pour matifier la peau
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
WO2003088897A2 (en) * 2001-04-06 2003-10-30 Affinium Pharmaceuticals, Inc. Fab i inhibitors
EP1396263A1 (en) * 2002-08-09 2004-03-10 Warner-Lambert Company Film coating for tablets and caplets
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
CN100415284C (zh) * 2002-12-30 2008-09-03 毛友昌 六味木香片的制备方法
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
ES2297067T3 (es) * 2003-03-19 2008-05-01 The Jordanian Pharmaceutical Manufacturing Co. Ltd. Composiciones farmaceuticas no higroscopicas que contienen acidos quinolinacarboxilicos de hidratados.
US8906413B2 (en) * 2003-05-12 2014-12-09 Supernus Pharmaceuticals, Inc. Drug formulations having reduced abuse potential
MXPA06000702A (es) * 2003-07-23 2006-04-11 Perrigo L Co Composicion que contiene fibra celulosica.
JP5087406B2 (ja) 2004-06-04 2012-12-05 アフィニウム ファーマシューティカルズ， インク． 治療薬ならびにその製造方法および使用方法
EP1809259B1 (en) * 2004-10-15 2014-12-03 Supernus Pharmaceuticals, Inc. Less abusable pharmaceutical preparations
JP2009518399A (ja) * 2005-12-05 2009-05-07 アフィニウム ファーマシューティカルズ， インク． Ｆａｂｉ阻害剤および抗菌剤としてのヘテロ環アクリルアミド化合物
WO2008009122A1 (en) 2006-07-20 2008-01-24 Affinium Pharmaceuticals, Inc. Acrylamide derivatives as fab i inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
DK2861608T3 (da) 2012-06-19 2019-06-24 Debiopharm Int Sa Prodrug-derivater af (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamid
CN108778286A (zh) 2016-02-26 2018-11-09 德彪药业国际股份公司 用于治疗糖尿病足感染的药物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286754A (en) 1986-01-21 1994-02-15 Bayer Aktiengesellschaft Pharmaceutical formulations of ciprofloxacin
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
US4957554A (en) 1989-08-16 1990-09-18 Minnesota Mining And Manufacturing Company Dimensionally-controlled ceramics
DE4120646A1 (de) 1991-06-22 1992-12-24 Bayer Ag 7-isoindolinyl-chinolon- und naphthyridoncarbonsaeure-derivate
CA2229786C (en) * 1995-08-29 2002-02-19 David Bruning Joseph Zwitterionic forms of trovafloxacin

Also Published As

Publication number Publication date
EA003247B1 (ru) 2003-02-27
ID23735A (id) 2000-05-11
KR19990068014A (ko) 1999-08-25
PL330981A1 (en) 1999-08-02
IL128051A0 (en) 1999-11-30
ZA99393B (en) 2000-07-21
CA2259698A1 (en) 1999-07-21
MA24747A1 (fr) 1999-10-01
HUP9900154A3 (en) 2000-12-28
EP0930068A3 (en) 1999-12-22
DZ2712A1 (fr) 2003-09-01
CO4810225A1 (es) 1999-06-30
AP1094A (en) 2002-08-19
PA8466701A1 (es) 2000-09-29
AU1217399A (en) 1999-08-12
AP9901443A0 (en) 1999-03-31
OA10958A (en) 2001-10-31
SK4299A3 (en) 2000-06-12
HUP9900154A2 (hu) 1999-09-28
US6187341B1 (en) 2001-02-13
SG70666A1 (en) 2000-02-22
YU2399A (sh) 2002-06-19
GT199900004A (es) 2000-07-08
TR199900089A3 (tr) 1999-10-21
NO990243D0 (no) 1999-01-20
TW518224B (en) 2003-01-21
NZ333838A (en) 2000-03-27
IS4947A (is) 1999-07-22
HU9900154D0 (en) 1999-03-29
TNSN99007A1 (fr) 2005-11-10
EA199900046A3 (ru) 1999-12-29
EP0930068A2 (en) 1999-07-21
KR100314977B1 (ko) 2001-11-24
PE20000169A1 (es) 2000-03-10
NO990243L (no) 1999-07-22
AU758381B2 (en) 2003-03-20
JPH11269072A (ja) 1999-10-05
HRP990023A2 (en) 1999-08-31
TR199900089A2 (xx) 1999-10-21
AR012780A1 (es) 2000-11-08
BR9900116A (pt) 2000-05-02
CN1227743A (zh) 1999-09-08
CA2259698C (en) 2003-04-15
EA199900046A2 (ru) 1999-08-26

Similar Documents

Publication Publication Date Title
BG103106A (bg) Таблетки тровафлоксацин мезилат
TR200103186T2 (tr) MEK enzimlerinin inhibitörleri olarak kinolin türevleri
BG103413A (bg) Производни на сулфиновата киселина, тяхното получаване и използване
DE3474631D1 (en) N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
BG106013A (bg) Нови съединения и състави като протеазни инхибитори
NZ520624A (en) 1,2,3,4-tetrahydroisoquinoline derivatives
IS7545A (is) 7-Arýl-3,9-díasabísýkló(3.3.1)nón-6-en afleiður og notkun þeirra sem renín hindra í meðferð á háþrýstingi, hjarta- og æða- eða nýrna sjúkdómum
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
AU2003269327A1 (en) Tetrahydroquinoline derivatives as crth2 antagonists
WO2002041889A3 (en) Indolsulfonyl compounds useful in the treatment of cns disorders
IL114599A0 (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containing them
ES2136037A1 (es) Inhibidores de sulfamida-metaloproteasa
CA2270964A1 (en) Benzonaphthyridines as bronchial therapeutics
CA2378428A1 (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
FI970147A (fi) Triatsoliyhdisteitä ja niiden käyttö dopamiini-D3-ligandeina
YU87202A (sh) Derivati arilmetilamina koji se koriste kao inhibitori triptaze
BG106239A (bg) Подобрени фармацевтични състави
AU5915100A (en) Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
CA2378834A1 (en) Pyrazinones, compositions containing such compounds
PT1427417E (pt) Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
BG102661A (bg) Бензо[с]хинолизинови производни, тяхното получаване и използване като инхибитори на 5 алфа-редуктази
CA2263846A1 (en) Novel pyranoside derivatives